Products
Platform
Research
Market
Learn
Compare Tata India Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.1 | 1.87 |
NAV | ₹31.01 | ₹40.60 |
Fund Started | 04 Dec 2015 | 25 Jun 2018 |
Fund Size | ₹1308.56 Cr | ₹6161.81 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.1
1.87
NAV
₹31.01
₹40.60
Fund Started
04 Dec 2015
25 Jun 2018
Fund Size
₹1308.56 Cr
₹6161.81 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | -1.47% | 3.41% |
3 Year | 23.49% | 28.37% |
5 Year | 19.42% | 21.82% |
1 Year
-1.47%
3.41%
3 Year
23.49%
28.37%
5 Year
19.42%
21.82%
Holding Analysis
Equity | 97.44% | 95.88% |
Cash | 2.56% | 4.12% |
Equity
97.44%
95.88%
Cash
2.56%
4.12%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.94% |
Cipla Ltd. | 6.92% |
Apollo Hospitals Enterprise Ltd. | 5.15% |
Healthcare Global Enterprises Ltd. | 4.85% |
Lupin Ltd. | 4.79% |
Torrent Pharmaceuticals Ltd. | 4.58% |
Aster DM Healthcare Ltd. | 4.40% |
Alkem Laboratories Ltd. | 4.31% |
Max Healthcare Institute Ltd. | 4.05% |
Divi's Laboratories Ltd. | 3.90% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.71% |
Dr. Reddy's Laboratories Ltd. | 9.47% |
Divi's Laboratories Ltd. | 9.23% |
Cipla Ltd. | 7.39% |
Aurobindo Pharma Ltd. | 6.53% |
Lupin Ltd. | 5.44% |
Alkem Laboratories Ltd. | 4.00% |
Mankind Pharma Ltd. | 3.50% |
Biocon Ltd. | 3.21% |
Gland Pharma Ltd. | 2.88% |
Fund Manager
Name | Meeta Shetty | Dharmesh Kakkad |
Start Date | 01 Nov 2019 | 16 Jan 2021 |
Name
Meeta Shetty
Dharmesh Kakkad
Start Date
01 Nov 2019
16 Jan 2021
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 04 Dec 2015 | 25 Jun 2018 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Dec 2015
25 Jun 2018
